Join to View Full Profile
970 N BroadwaySuite 101Yonkers, NY 10701
Phone+1 914-969-1600
Fax+1 914-969-1685
Dr. Hermanto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ulrich Hermanto is a seasoned Radiation Oncologist based in Yonkers, NY. He completed his Ph.D. in Molecular Biology and Cancer Biology and later his MD from the Icahn School of Medicine at Mount Sinai. His professional experience includes serving as the Medical Director at Montefiore Yonkers and an Attending Physician at 21st Century Oncology. He has made significant contributions in his field, as seen in his publications in esteemed journals such as JCO Precision Oncology, Annals of Surgical Oncology, Cell Growth & Differentiation, Oncogene, and Molecular and Cellular Biology. In his career, Dr. Hermanto also won the CMS Meaningful Use Stage 1 Certification.
Education & Training
University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2003 - 2007
Icahn School of Medicine at Mount Sinai/Morningside/WestInternship, Internal Medicine, 2002 - 2003- Icahn School of Medicine at Mount SinaiClass of 2002
- Icahn School of Medicine at Mount SinaiPost-Doctoral Fellowship, 1999 - 2000
Mount Sinai School of Medicine of NYUPh.D., Molecular Biology, Cancer Biology, 1994 - 1999
Certifications & Licensure
NY State Medical License 2007 - 2026
NV State Medical License 2016 - 2025
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Radiation Oncology EMR, Varian Medical Systems, 2013-2014
Publications & Presentations
PubMed
- 1 citationsLymphomatous Meningitis From Anaplastic Lymphoma Kinase+ Anaplastic Large T-Cell Lymphoma Treated With Lorlatinib: A Case Report.Smitha Mellacheruvu, Mark N Sayegh, R Alejandro Sica, Haiying Cheng, Maria Laureana Santos-Zabala
JCO Precision Oncology. 2022-02-01 - 28 citationsTARGIT-R (Retrospective): 5-Year Follow-Up Evaluation of Intraoperative Radiation Therapy (IORT) for Breast Cancer Performed in North America.Stephanie A. Valente, Rahul D. Tendulkar, Sheen Cherian, Chirag Shah, Darrel L. Ross
Annals of Surgical Oncology. 2021-01-12 - 2 citationsCorrection for Zhang et al., RACK1 Recruits STAT3 Specifically to Insulin and Insulin-Like Growth Factor 1 Receptors for Activation, Which Is Important for Regulating ...Weizhou Zhang, Cong S. Zong, Ulrich Hermanto, Pablo Lopez-Bergami, Ze'ev Ronai
Molecular and Cellular Biology. 2017-03-15
Authored Content
- Intraoperative Radiation Therapy for Early Stage Breast CancerOctober 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
